RA0517

antibody from Oursmab
Targeting: MUC16 CA125, FLJ14303
Provider product page for RA0517
Western blot
ELISA
Immunocytochemistry
Flow cytometry
Functional assay

Antibody data

Product number
RA0517 - Provider product page
Provider
Oursmab
Product name
Sofituzumab (Biosimilar Reference Antibody) (MUC16)
Antibody type
Monoclonal
Description
Sofituzumab is a humanized IgG1 kappa monoclonal antibody targeting MUC16 (CA125), a large transmembrane glycoprotein overexpressed in epithelial ovarian cancer and other malignancies. By binding to MUC16, it aims to inhibit tumor growth and metastasis, and may also facilitate antibody-dependent cellular cytotoxicity (ADCC). It is being developed as a therapeutic agent for MUC16-positive cancers, often in combination with chemotherapy or other targeted therapies.
Reactivity
Human
Isotype
IgG
Vial size
100 ¦Ìg,1 mg,5 mg,10 mg,25 mg,50 mg,100 mg
Concentration
Bottled at the concentration indicated on the vial.
Storage
Store at -20¡ãC or -80¡ãC. Avoid repeated freeze.
MUC16 protein structure - RA0517 shown in red.